← Eichor
Study identifier: NCT05119244 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Environment and Lung Cancer

Condition: Cannabis Use  ·  Sponsor: Centre Chirurgical Marie Lannelongue

PhaseNA
Planned participants150
Who can joinAll sexes, 18 Years to 59 Years
Healthy volunteersNo

About this study

Cannabis is the most consumed drug in the world and the French are the main consumers in Europe. The most recognized effects of cannabis on human health are of a neuro-psychic nature. The medical literature on the effects of cannabis on the lung in general, and on lung carcinogenesis in particular, is most often reassuring (Tashkin, Chest 2018; Zhang, Int J Cancer 2015; Ghasemiesfe JAMA Netw. Open. 2019), despite the fact that the concentration of carcinogens in cannabis smoke is higher than that contained in tobacco smoke (Moir, Chem. Res. Toxicol. 2008), and that cannabis smoking has been implicated in the occurrence of ENT cancers. Rather, research focuses on the therapeutic effects of cannabis, especially analgesics, and even on its possible anti-tumor virtues (Abrams, Jama Oncol. 2020). These reassuring data should, however, be viewed with a great deal of caution. On the one hand, the illegal nature of cannabis in most countries and its frequent association with tobacco consumption make studies on the subject difficult and often biased. On the other hand, the daily practice of oncologists, who observe numerous cases of advanced and rapidly progressive lung cancer occurring in young patients who are heavy users of cannabis, raises suspicion of an unrecognized role of cannabis in lung carcinogenesis. In a preliminary multicenter study on French patients under 50 years of age operated for primary lung cancer (Betser, ERJ 2021), we demonstrated that cannabis consumption was…

This description comes directly from the study's public registry record.

Talk to the study team

Pauline PRADERE, MD  ·  01.40.94.22.79  ·  p.pradere@ghpsj.fr

Always discuss trial participation with your own doctor first.

Locations (3)

Centre Chirurgical Marie LannelongueLe Plessis-Robinson, FranceRecruiting
Hopital Paris Saint JosephParis, FranceCompleted
Institut Gustave RoussyVillejuif, FranceCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05119244